Sunshine Biopharma Inc.
13F holders, Q2 2025 (June 30)At the end of Q2 2025, 12 institutions reported holding Sunshine Biopharma Inc. in their 13F filings, up 1 from Q1 2025. 3 opened new positions and 1 sold out. The largest holders were Citadel Advisors ($91K), Renaissance Technologies ($78K) and SBI Securities Co., Ltd. ($10K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Sunshine Biopharma Inc.
- CUSIP
- 867781700
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $171K |
| Exits | 1 | $2 |
All 13F filers, Q1 2025 → Q2 2025: 120,703 shares bought and 19,680 shares sold, net +101,023 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Citadel Advisors | 0.00% | New | 63,431 | $91K |
| Renaissance Technologies | 0.00% | New | 54,093 | $78K |
| SBI Securities Co., Ltd. | 0.00% | Add +28.2% | 6,694 | $10K |
| Morgan Stanley | 0.00% | No change | 3,834 | $6K |
| Sabby Management, LLC | 0.02% | New | 1,558 | $2K |
| UBS Group AG | 0.00% | Reduce -99.0% | 206 | $297 |
| Osaic Holdings, Inc. | 0.00% | Add +7500.0% | 152 | $218 |
| National Bank of Canada | 0.00% | No change | 10 | $14 |
| Bank of America Corp. | 0.00% | No change | 5 | $7 |
| Farther Finance Advisors, LLC | 0.00% | No change | 1 | $1 |
| TD Waterhouse Canada Inc. | 0.00% | No change | 1 | $1 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is SUNSHINE BIOPHARMA INC's weight in each manager's 13F, not the share of Sunshine Biopharma Inc. the manager owns.